Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06
- PMID: 1917610
- DOI: 10.1016/0360-3016(91)90757-u
Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06
Abstract
One hundred four patients with stage T-1b, T-2 N-O M-O prostate cancer were treated with external beam irradiation as part of RTOG 77-06. Lymph nodes were negative by lymph node dissection in 16 patients with T-1b and 88 patients with T-2 cancers. Survival exceeds age matched expected survival for the 10 years of observation (63% vs 59% at 10 years). Patterns of failure at 10 years show 87% of patients were free of isolated local recurrence, 79% free of metastatic failure, 67% free of any failure, and cause specific survival shows 86% free of cancer death at 10 years. The outcome of this group is equal or superior to reports of radical prostatectomy in similar stage patients.
Similar articles
-
The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation.Int J Radiat Oncol Biol Phys. 1988 Feb;14(2):243-8. doi: 10.1016/0360-3016(88)90427-0. Int J Radiat Oncol Biol Phys. 1988. PMID: 3276653 Review.
-
Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.Cancer. 2001 Oct 15;92(8):2084-94. doi: 10.1002/1097-0142(20011015)92:8<2084::aid-cncr1549>3.0.co;2-c. Cancer. 2001. PMID: 11596024
-
Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification.Int J Radiat Oncol Biol Phys. 1992;23(2):293-8. doi: 10.1016/0360-3016(92)90744-3. Int J Radiat Oncol Biol Phys. 1992. PMID: 1587749 Clinical Trial.
-
High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1405-10. doi: 10.1016/j.ijrobp.2011.04.054. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 21640507
-
Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.Cancer. 1998 Sep 1;83(5):989-1001. doi: 10.1002/(sici)1097-0142(19980901)83:5<989::aid-cncr26>3.0.co;2-q. Cancer. 1998. PMID: 9731904 Review.
Cited by
-
[The hormone refractory prostate cancer - a challenge for the internal specialist].Wien Med Wochenschr. 2007;157(7-8):145-8. doi: 10.1007/s10354-007-0397-7. Wien Med Wochenschr. 2007. PMID: 17492409 Review. German.
-
[The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].Strahlenther Onkol. 1997 Feb;173(2):98-105. doi: 10.1007/BF03038929. Strahlenther Onkol. 1997. PMID: 9072845 German.
-
The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.Curr Urol Rep. 2005 May;6(3):194-209. doi: 10.1007/s11934-005-0008-3. Curr Urol Rep. 2005. PMID: 15869724 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical